Proximagen buys Minster for £4.3m Health / Medicine Related News
The specialist maker of drugs for treating neuro-degenerative diseases is to make its second acquisition since raising £50m on Aim last summer Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,